Gaetano Guglielmino serves as Chief Commercial Officer at TREACE MEDICAL CONCEPTS, INC., where they oversee executive responsibilities. Since joining the company, Gaetano Guglielmino has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 22, 2026 involved receiving (via award) 150,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 22, 2026 | TMCI | $0 | Award | 150,000 | $N/A | Discretionary |
Gaetano Guglielmino currently holds 490,901 shares of TREACE MEDICAL CONCEPTS, INC. (TMCI), valued at approximately $0. This represents their equity stake as Chief Commercial Officer.
Based on SEC Form 4 filings, Gaetano Guglielmino has been a net neutral trader of TMCI stock. They have purchased $0 and sold $0 worth of shares.
Gaetano Guglielmino's most recent insider trade was on Jan 22, 2026, when they sold 150,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted